Latest News
Clearwater International acted as sole financial adviser to Palero Capital on the sale of 100 per cent of the share capital of Lausitzer Analytik (LAG) to SYNLAB, a portfolio company of Cinven.
LAG, established in 1993 and headquartered in Spremberg, Germany, is a laboratory testing specialist in fuel, oil and environmental testing with a leading position in Southern Brandenburg and Northern Saxony regions.
The company provides a wide range of environmental testing services including water, soil and air analysis with in-depth expertise in fuel, coal and oil analytics for clients in the mining, industrial and energy producing sectors.
OceanRock Investments, manager of Meritas SRI Funds, has invested in InvestEco Capital, a firm focussed on investing in high-growth sustainable companies.
Meritas SRI Funds is making an investment in the InvestEco Sustainable Food Fund II as part of the Meritas fund family's broader Impact Investing mandate, which includes building healthier, sustainable communities in Canada, the US and around the world.
The InvestEco Sustainable Food Fund II focuses on high-growth, expansion-stage private companies in North America that are promoting health and sustainability in the food and agricultural sector. The fund is managed by InvestEco Capital, a leader in impact investing
Vulturis Financial Data Services has launched a venture-capital initial public offering yield index.
Based on historical data pertaining to returns of IPOs, the index weighs the average returns and exhibits the feasibility and viability of offering public stock for a start-up.
The VC IPO Yield Index shows the return of VC IPOs relative to the number of filings on a monthly basis.
The ratio uses the adjusted liquidity, or proceeds, of initial public offerings, giving founders a reference point when considering going public.
Vulturis launched the index as a tool for both angel investors and entrepreneurs to
Australian oncology-focused biotechnology company Novogen has acquired Glioblast, a privately-held, neuro-oncology focused Australian biotechnology company.
The transaction includes an upfront payment of AUD2.1 million, comprising AUD600,000 in cash and ordinary fully-paid shares valued at AUD1.5 million.
The shareholders of Glioblast will be eligible for further payments in cash or equity on the achievement of performance-related milestones.
The first two of these milestones provide for the issue of ordinary fully-paid shares valued at AUD1.25 million respectively on commencement and successful completion of a phase II clinical trial of GDC-0084, with the actual number of shares determined on the basis
Kuang-Chi Group has launched its second Global Community of Innovation (GCI) fund, which will invest up to USD250 million in companies developing technology in industries including robotics, internet-of-things, telecommunications, and digital health.
The fund has a focus on global start-ups and follows a previous investment of USD50 million in similar fields.
Through investments of the first GCI fund, Kuang-Chi has taken stakes in companies with a focus on innovative and disruptive technologies, including video intelligence provider Agent Video Intelligence (Agent Vi).
Itsik Kattan, CEO of AgentVi, says: "After Kuang-Chi became a strategic investor in Agent Vi, our cooperation
Eversheds has appointed Pinsent Masons partner Andy Phillips to its Manchester corporate team.
Phillips, who is expected to join Eversheds’ Manchester office in early 2017, will lead the Eversheds private equity group in the North West.
Phillips has experience and expertise advising PE institutions and management teams and sellers on management buy-outs, exits and private company M&A within a range of sectors.
Simon Masters, Eversheds corporate head for Manchester, says: “We have taken our time and been very careful in selecting the right person to lead our private equity team in Manchester. I know we have the right person
Oaktree Capital Group has appointed Steven Gilbert to its board of directors, effective 24 October 2016.
Gilbert is the founder and chairman of the board of institutional investment firm Gilbert Global Equity Partners.
Howard Marks, Oaktree’s co-chairman, says: “Over three decades, Steve has had an impressive career in private equity investing, investment banking, investment management and law. Additionally, he has owned and operated businesses as well as served as a corporate director for numerous companies. We are excited to welcome Steve to our board and look forward to benefiting from his insight and experience.”
“It is a privilege to
Technology entrepreneurs who get funding from venture capitalists go public sooner and have more impactful innovation than those who partner with angel investors, according to research from the University at Buffalo School of Management.
Published in the Journal of Business Venturing, the study found that high-tech start-ups that received funding from venture capitalists were able to find a buyer or issue stock sooner than those that received angel investment — and the patents issued by venture capital-funded firms had greater reach.
“Angels and venture capitalists are both critical to innovation in business,” says study co-author Supradeep Dutta, assistant professor
Bowside Capital, a private investment firm that specialises in the North American private equity, small capitalisation market, has appointed Dru Rushing as a vice president.
Rushing will be involved in sourcing, due diligence and monitoring of private equity investments.
Prior to joining Bowside, Rushing spent over seven years as an investment banker focused on the business services and healthcare sectors.
He was most recently a vice president in the Atlanta office of Raymond James Financial, where he participated in over 20 transactions in mergers and acquisitions, debt capital markets, equity capital markets and private placements.
Previously, Rushing
TorQuest Partners has completed the sale of Global Traffic Technologies (GTT) to Gilbarco.
Terms of the transaction have not been disclosed.
GTT provides priority traffic control for public transit and emergency vehicles, with a growing presence in the broader public transit market for solutions that improve public transportation efficiency, safety and on-time performance.
Michael Hollend, a partner at TorQuest Partners, says: "GTT, a TorQuest Fund II investment, demonstrated an ability to leverage its intellectual property to innovate and develop products for emergency vehicles and transit systems, in North America and abroad. On behalf of TorQuest, we would like
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
